CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 90 filers reported holding CYTEK BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,639 | -49.6% | 296,900 | -16.0% | 0.00% | -25.0% |
| Q1 2023 | $3,249 | -18.8% | 353,500 | -9.8% | 0.00% | -20.0% |
| Q4 2022 | $4,000 | -99.9% | 391,800 | +84.9% | 0.01% | +25.0% |
| Q3 2022 | $3,119,000 | +78.4% | 211,900 | +30.1% | 0.00% | +100.0% |
| Q2 2022 | $1,748,000 | +198.8% | 162,900 | +200.0% | 0.00% | +100.0% |
| Q1 2022 | $585,000 | -67.1% | 54,300 | -50.2% | 0.00% | -50.0% |
| Q4 2021 | $1,779,000 | – | 109,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,300,000 | $13,273,000 | 8.92% |
| Miura Global Management | 780,000 | $7,963,800 | 4.01% |
| RA Capital Management | 13,381,054 | $136,620,561 | 2.77% |
| HHLR ADVISORS, LTD. | 8,684,530 | $88,669,051 | 1.87% |
| Brown Capital Management | 5,107,878 | $52,151,434 | 0.86% |
| Perceptive Advisors | 1,289,534 | $13,166,142 | 0.37% |
| Hillsdale Investment Management Inc. | 344,529 | $3,517,641 | 0.30% |
| PURA VIDA INVESTMENTS, LLC | 420,749 | $4,295,847 | 0.22% |
| FOX RUN MANAGEMENT, L.L.C. | 19,881 | $202,985 | 0.08% |
| INNOVIS ASSET MANAGEMENT LLC | 14,565 | $148,709 | 0.07% |